Peer-Reviewed Publications (trainees directly supervised by me are underlined):

  1. Shaw C, Gibson W. Assessing Quality-of-Life of Patients Taking Mirabegron for Overactive Bladder. Ther Clin Risk Manag. 2023 Jan 10;19:27-33. doi: 10.2147/TCRM.S269318. PMID: 36647532; PMCID: PMC9840370.

  2. Olagundoye O, Kung JY, Gibson W, Wagg A. Urinary incontinence in older men: protocol for a scoping review of risk factors. BMJ Open. 2023 Feb 10;13(2):e068956. doi: 10.1136/bmjopen-2022-068956. PMID: 36764714; PMCID: PMC9923276.

  3. Gibson W, Wagg A. Pessaries for pelvic organ prolapse in women with severe dementia: an ethical challenge. Int Urogynecol J. 2023 May;34(5):1007-1008. doi: 10.1007/s00192-023-05478-5. Epub 2023 Feb 14. PMID: 36786853.  

  4. Suskind AM, Vaittinen T, Gibson W, Hajebrahimi S, Ostaszkiewicz J, Davis N, Dickinson T, Spencer M, Wagg A. International Continence Society white paper on ethical considerations in older adults with urinary incontinence. Neurourol Urodyn. 2022 Jan;41(1):14-30. doi: 10.1002/nau.24795. Epub 2021 Sep 23. PMID: 34558106.         

  5. Hosseini F, Mullins S, Gibson W, Thake M. Acute pain management for older adults. Clin Med (Lond). 2022 Jul;22(4):302-306. doi: 10.7861/clinmed.22.4.ac-p. PMID: 35882483; PMCID: PMC9345205.   

  6. Mullins S, Hosseini F, Gibson W, Thake M. Physiological changes from ageing regarding pain perception and its impact on pain management for older adults. Clin Med (Lond). 2022 Jul;22(4):307-310. doi: 10.7861/clinmed.22.4.phys. PMID: 35882493; PMCID: PMC9345212.    

  7. Gibson W, Jones A, Hunter K, Wagg A. Urinary urgency acts as a source of divided attention leading to changes in gait in older adults with overactive bladder. PLoS One. 2021 Oct 4;16(10):e0257506. doi: 10.1371/journal.pone.0257506. PMID: 34606514; PMCID: PMC8489708.

  8. Gibson W, Johnson T, Kirschner-Hermanns R, Kuchel G, Markland A, Orme S, Ostaszkiewicz J, Szonyi G, Wyman J, Wagg A. Incontinence in frail elderly persons: Report of the 6th International Consultation on Incontinence. Neurourol Urodyn. 2021 Jan;40(1):38-54. doi: 10.1002/nau.24549. Epub 2020 Oct 21. PMID: 33085806.      

  9. Gibson W, Makhani A, Hunter KF, Wagg A. Do Older Adults with Overactive Bladder Demonstrate Impaired Executive Function Compared to Their Peers Without OAB? Can Geriatr J. 2020 Dec 1;23(4):329-334. doi: 10.5770/cgj.23.423. PMID: 33282051; PMCID: PMC7704076.               

  10. Gibson W, Morrison R, Wagg A, Hunter KF. Is the strong desire to void a source of diverted attention in healthy adult volunteers? Neurourol Urodyn. 2020 Jan;39(1):324-330. doi: 10.1002/nau.24201. Epub 2019 Nov 29. PMID: 31782977.   

  11. Makhani A, Thake M, Gibson W. Mirabegron in the Treatment of Overactive Bladder: Safety and Efficacy in the Very Elderly Patient. Clin Interv Aging. 2020 Apr 23;15:575-581. doi: 10.2147/CIA.S174402. PMID: 32368024; PMCID: PMC7185319.       

  12. Yeung J, Jones A, Jhangri GS, Gibson W, Hunter KF and Wagg A. Toileting Disability in Older People Residing in Long-term Care or Assisted Living Facilities: A Scoping Review of the Literature. J Wound Ostomy Continence Nurs, 2019. 46(5): p. 424-433.

  13. Allison SJ and Gibson W. Mirabegron, alone and in combination, in the treatment of overactive bladder: real-world evidence and experience. Ther Adv Urol, 2018. 10(12): p. 411-419.

  14. Gibson W, Hunter KF, Camicioli R, Booth J, Skelton DA, Dumoulin C, Paul L and Wagg A. The association between lower urinary tract symptoms and falls: Forming a theoretical model for a research agenda. Neurourol Urodyn, 2018. 37(1): p. 501-509.

  15. Gibson W and Wagg A. Trends in the use of older overactive bladder agents and uptake of fesoterodine and mirabegron in Canada. Neurourol Urodyn, 2018. 37(8): p. 2977-2978.

  16. Surkan MJ and Gibson W. Interventions to Mobilize Elderly Patients and Reduce Length of Hospital Stay. Can J Cardiol, 2018. 34(7): p. 881-888.

  17. Gibson W, MacDiarmid S, Huang M, Siddiqui E, Stolzel M, Choudhury N and Drake MJ. Treating Overactive Bladder in Older Patients with a Combination of Mirabegron and Solifenacin: A Prespecified Analysis from the BESIDE Study. Eur Urol Focus, 2017. 3(6): p. 629-638.

  18. Johnson G and Gibson W. A Response to "Top Ten Myths Regarding the Diagnosis and Treatment of Urinary Tract Infections". J Emerg Med, 2017. 52(5): p. e213.

  19. Gibson W and Wagg A. Incontinence in the elderly, 'normal' ageing, or unaddressed pathology? Nat Rev Urol, 2017. 14(7): p. 440-448.

  20. Gibson W, Hainsworth AJ, Morris SJ, Cartwright R, Alloussi S and Dmochowski R. What was hot at ICS 2016? Neurourol Urodyn, 2017. 36(8): p. 2176-2180.

  21. Gibson W and Wagg A. Are older women more likely to receive surgical treatment for stress urinary incontinence since the introduction of the mid-urethral sling? An examination of Hospital Episode Statistics data. BJOG, 2016. 123(8): p. 1386-92.

  22. Gibson W, Harari D, Husk J, Lowe D and Wagg A. A national benchmark for the initial assessment of men with LUTS: data from the 2010 Royal College of Physicians National Audit of Continence Care. World J Urol, 2016. 34(7): p. 969-77.

  23. Gibson W, Wagg A and Hunter KF. Urinary incontinence in older people. Br J Hosp Med (Lond), 2016. 77(2): p. C27-32.

  24. Howlett M, Gibson W, Hunter KF, Chambers T and Wagg A. Nocturnal Enuresis in Older People: Where Is the Evidence and What Are the Gaps? J Wound Ostomy Continence Nurs, 2016. 43(4): p. 401-6.

  25. Wagg A, Gibson W, Ostaszkiewicz J, Johnson T 3rd, Markland A, Palmer MH, Kuchel G, Szonyi G and Kirschner-Hermanns R. Urinary incontinence in frail elderly persons: Report from the 5th International Consultation on Incontinence. Neurourol Urodyn, 2015. 34(5): p. 398-406.

  26. Koch M, Cartwright R, Tikkinen KA, Siddiqui NY, Couri BM, Gibson W, Igualada-Martinez P and Chapple CR. What was hot at the ICS meeting 2014? Neurourol Urodyn, 2015. 34(3): p. 206-12.

  27. Orme S, Morris V, Gibson W and Wagg A. Managing Urinary Incontinence in Patients with Dementia: Pharmacological Treatment Options and Considerations. Drugs Aging, 2015. 32(7): p. 559-67.

  28. Gibson W and Wagg A. Urinary Tract Infections in the Elderly. Current Bladder Dysfunction Reports, 2015. 10(3): p. 222-226.

  29. Gibson W and Wagg A. Urinary incontinence in the frail elderly: what do we still need to learn? Clinical Practice, 2014. 11(4): p. 431-440.

  30. Gibson W, Athanasopoulos A, Goldman H, Madersbacher H, Newman D, Spinks J, Wyndaele JJ and Wagg A. Are we shortchanging frail older people when it comes to the pharmacological treatment of urgency urinary incontinence? Int J Clin Pract, 2014. 68(9): p. 1165-73.

  31. Gibson W and Wagg A. New horizons: urinary incontinence in older people. Age Ageing, 2014. 43(2): p. 157-63.


Books/Chapters

  1. Bower W, Gibson W, Hunter K, Kirschner-Hermanns R, Kuchel G, Morris V, Ostaszkiewicz J, Suskind A, Suzuki M, Wagg A, Wyman J. 7th International Consultation on Incontinence: Incontinence in Frail Older Adults, International Continence Society, Bristol, 2023.

  2. Gibson W. Faecal incontinence, in Pathy's Principles and Practice of Geriatric Medicine. Wiley-Blackwell, London,2022.

  3. Lee R, Gibson W, Wagg A.  Chapter 35: Continence and Elimination. in A Comprehensive Guide to Rehabilitation of the Older Patient.  Elsevier.  2022, March 21.

  4. Gibson W, Wagg A. Overactive bladder/urgency UI: Pathology, presentation, diagnosis and management. In   2015.  Wound Ostomy and Continence Nurses Society Core Curriculum: Continence Management, 2017 (chapter).


Peer Reviewed Abstracts

  1. Fan K, Gibson W, Wagg A. Correlating Subjective Patient Perception with Quantified Symptom Scores in Patients with Lower Urinary Tract Symptom (LUTS)  Presented at the International Continence Society annual scientific meeting in Vienna, Italy; September 7-11, 2022.

  2. Maradiya R, Rajabali S, Gibson W, Lee R, Hunter K, Wagg A. A comparative assessment of frailty and comorbidity in older patients with and without overactive bladder; Presented at Annual Meeting of the International Continence Society, virtually, November 18-21, 2020.

  3. Thake M, Al-Mohammad A, Gibson W. What is known about lower urinary tract symptoms (LUTS) in heart failure? A scoping review. Presented at Annual Meeting of the International Continence Society virtually, November 18-21, 2020.

  4. Gibson W, Kolahdooz F, Laboucan M, Otway M, Wagg A, Sharma S. Urinary Incontinence in Indigenous Seniors in Northern Canada; Presented at Annual Meeting of the International Continence Society virtually, November 18-21, 2020.

  5. Kerber K, Gibson W, McKeen J, Laboucan L, Irlbacher-Fox S, Kandola K, Corriveau A, Wagg A, Sharma S, Food Security and Health Status of Indigenous Seniors in Northern Canada, Presented at the Annual Scientific Meeting of the Canadian Geriatrics Society virtually, April 13-15, 2020.

  6. Wagg A, Gibson WR, Carlsson M, Elsobky M. Subjective and objective response to treatment of overactive bladder: a pooled analysis of randomised controlled trials of fesoterodine in patients of >65 years. Presented at EAU, Virtually, March 2020.

  7. Gibson W, Makhani A, Wagg A, Hunter K. Is the strong desire to void a source of diverted attention in older adults without lower urinary tract symptoms? Presented at 49th Annual ICS Meeting, Gothenburg Sweden, Sept 3 – 6, 2019.

  8. Gibson W, Makhani A, Wagg A, Hunter K. Do older adults with OAB demonstrate impaired executive function compared to their peers without OAB? Presented at 49th Annual ICS Meeting, Gothenburg Sweden, Sept 3 – 6, 2019.

  9. W Gibson, K Hunter, A Wagg. Is urinary urgency a source of diverted attention leading to gait changes in older people with overactive bladder? Presented at Canadian Urological Association Annual Meeting in Quebec City, QC.  June 29-July 1, 2019.

  10. Makhani A, Qureshi S, Hunter KF, Wagg A, Gibson W. Do Older Adults with Overactive Bladder Demonstrate Impairment in Executive Function Compared to Their Peers without OAB? Presented at the Canadian Geriatric Society conference, May 2-4, 2019, Halifax, Nova Scotia. 

  11. Morrison R, Hunter KF, Wagg A, Gibson W. Is the strong desire to void a source of diverted attention in healthy volunteers? Presented at International Continence Society Conference in Philadelphia, USA; August 28 – 31, 2018.

  12. Fernando J, Gibson W, Hunter K, Wagg A. Time in Soiled Pads: What’s acceptable to older patients and what do direct caregivers think? Presented at Annual Meeting of the International Continence Society Sept 12-15, 2017 Florence Italy.

  13. Wagg A, Sheri N, Gibson W, Hunter K. What treatments for urinary incontinence and lower urinary tract symptoms are acceptable and what outcomes desirable to older people? Presented at Annual Meeting of the International Continence Society Sept 12-15, 2017 Florence Italy.

  14. Gibson W, Wagg A, Hunter K. Measuring Gait Variables using motion capture in older women with urinary urgency: a pilot study.  Presented at Annual Meeting of the International Continence Society Sept 12-15, 2017 Florence Italy.

  15. Dai J, Gibson W, Hunter K, Wagg A. Polypharmacy and multimorbidity in older people with bladder dysfunction: data from a secondary care database. Presented at IUGA Conference in Cape Town, South Africa, August 2-6, 2016.

  16. Howlett M, Gibson W, Hunter K, Chambers T, Wagg A. Nocturnal enuresis in older people: where is the evidence and what are the gaps Canadian Urological Association Annual Conference, Ottawa, ON, June 27-30, 2015.

  17. Gibson W, Wagg A. Homeopathy, chiropractic, massage, aromatherapy, osteopathy, and reflexology for urinary incontinence and lower urinary tract symptoms in adults: A scoping review.  Poster presentation, Canadian Urological Association Annual Conference, Ottawa, ON, June 27-30, 2015.

  18. Gibson W, Wagg A. Are older women more likely to receive less invasive surgical al options for stress urinary incontinence since the introduction of the mid-urethral sling? Presented at EAU 2014, Stockholm, Sweden.

Make it stand out